Radius Health (RDUS) Tops Q2 EPS by 9c

Radius Health (NASDAQ: RDUS) reported Q2 EPS of ($0.67), $0.09 better than the analyst estimate of ($0.76). Revenue for the quarter came in at $50.1 million versus the consensus estimate of $47.61 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• Philip Morris International (PM) Tops Q1 EPS by 9c; raises guidance
• NextEra Energy Partners (NEP) Tops Q1 EPS by 50c